查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1966054

全球生物分析服務市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

Global Bioanalytical Services Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 152 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

預計生物分析服務市場將從 2025 年的 46.6 億美元成長到 2034 年的 142.4 億美元，2026 年至 2034 年的複合年成長率為 13.2%。

受製藥和生物技術行業藥物研發和臨床研究需求不斷成長的推動，全球生物分析服務市場正經歷顯著成長。慢性病盛行率的上升，以及生物製藥和生物相似藥的廣泛應用，大大增加了對精準生物分析檢測的需求。有關藥品安全性和有效性的監管要求進一步強化了對專業分析服務的需求。質譜和層析法技術的進步提高了靈敏度和效率，使服務供應商能夠處理複雜的生物樣本，並支援全球範圍內的大規模臨床試驗。

主要成長要素包括製藥公司為降低營運成本和縮短產品上市時間而大幅增加的外包活動。特別是中小型生物技術公司，它們依賴受託研究機構（CRO）來獲取生物分析測試方面的專業知識。個人化醫療和基於生物標記的研究的日益普及也增強了對先進分析平台的需求。此外，新興國家對生命科學研究的政府資助以及臨床試驗計畫的擴展也顯著促進了市場成長，並推動了研究機構和服務供應商之間的策略合作。

展望未來，自動化技術、人工智慧數據分析和高通量篩檢技術等創新可望推動市場發展。資料管理和法規遵循的數位化平台整合將進一步簡化工作流程。細胞和基因療法的發展有望帶來成長機遇，因為精準的生物分析檢驗至關重要。隨著藥物研發管線的多元化和全球監管力度的加強，未來幾年對可靠、擴充性且技術先進的生物分析服務的需求預計將持續成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球生物分析服務市場：依服務類型分類

  • 市場分析、洞察與預測
  • 免疫化學服務
  • 定量免疫檢測
  • 基於細胞的中和試驗
  • LCMS方法開發
  • 藥物發現階段
  • LCMS樣品
  • GCP
  • 生物標記測量
  • 蛋白質分析
  • 其他

第5章 全球生物分析服務市場：按類型分類

  • 市場分析、洞察與預測
  • 低分子量生物分析
  • 聚合物生物分析
  • 其他

第6章 全球生物分析服務市場：依最終用戶分類

  • 市場分析、洞察與預測
  • 製藥和生物技術公司
  • 受託研究機構
  • 其他

第7章 全球生物分析服務市場：依地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • UAE
    • 以色列
    • 南非
    • 其他中東和非洲國家

第8章 競爭情勢

  • 最新趨勢
  • 公司分類
  • 供應鏈和銷售管道合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第9章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • PPD Inc
    • ICON Plc
    • Laboratory Corporation Of America
    • Charles River Laboratories International Inc
    • Syneos Health
    • SGS SA
    • Toxikon Inc
    • Intertek Group
    • Pace Analytical Services
    • Medpace
    • PRA Health Sciences
    • WuXi AppTec
    • IQVIA
    • Eurofins Scientific
簡介目錄
Product Code: VMR11210212

The Bioanalytical Services Market size is expected to reach USD 14.24 Billion in 2034 from USD 4.66 Billion (2025) growing at a CAGR of 13.2% during 2026-2034.

The Global Bioanalytical Services Market has experienced substantial growth due to the rising demand for drug development and clinical research across pharmaceutical and biotechnology industries. Increasing prevalence of chronic diseases and the expansion of biologics and biosimilars have significantly boosted the need for accurate bioanalytical testing. Regulatory requirements for drug safety and efficacy have further strengthened the demand for specialized analytical services. Technological advancements in mass spectrometry and chromatography techniques have improved sensitivity and efficiency, enabling service providers to handle complex biological samples and support large-scale clinical trials worldwide.

Key growth drivers include the surge in outsourcing activities by pharmaceutical companies aiming to reduce operational costs and accelerate time-to-market. Small and mid-sized biotech firms particularly rely on contract research organizations for bioanalytical testing expertise. The increasing adoption of personalized medicine and biomarker-based studies has also intensified demand for advanced analytical platforms. Moreover, government funding for life sciences research and expanding clinical trial pipelines in emerging economies contribute significantly to market expansion, fostering strategic collaborations between research institutions and service providers.

Looking ahead, the market is expected to benefit from innovations in automation, artificial intelligence-driven data analysis, and high-throughput screening technologies. The integration of digital platforms for data management and regulatory compliance will further streamline workflows. Growth opportunities are likely to emerge from cell and gene therapy development, where precise bioanalytical validation is essential. As pharmaceutical pipelines diversify and regulatory scrutiny increases globally, the demand for reliable, scalable, and technologically advanced bioanalytical services will continue to strengthen in the coming years.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Service

  • Immunochemistry Services
  • Quantitative Immunoassays
  • Cell-based Neutralization Assays
  • LCMS Method Development
  • Discovery Phase Bioanalysis
  • LCMS Sample Bioanalysis
  • GCP Bioanalysis Service
  • Biomarker Assays
  • Protein Analysis
  • Others

By Type

  • Small Molecule Bioanalysis
  • Large Molecule Bioanalysis
  • Others

By End-user

  • Pharma & Biotechnology Companies
  • Contract Research Organizations
  • Others

COMPANIES PROFILED

  • PPD Inc, ICON Plc, Laboratory Corporation Of America, Charles River Laboratories International Inc, Syneos Health, SGS SA, Toxikon Inc, Intertek Group, Pace Analytical Services, Medpace, PRA Health Sciences, WuXi AppTec, IQVIA, Eurofins Scientific

We can customise the report as per your requriements

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL BIOANALYTICAL SERVICES MARKET: BY SERVICE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Service
  • 4.2. Immunochemistry Services Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Quantitative Immunoassays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Cell-based Neutralization Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.5. LCMS Method Development Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.6. Discovery Phase Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.7. LCMS Sample Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.8. GCP Bioanalysis Service Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.9. Biomarker Assays Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.10. Protein Analysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.11. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL BIOANALYTICAL SERVICES MARKET: BY TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Type
  • 5.2. Small Molecule Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Large Molecule Bioanalysis Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL BIOANALYTICAL SERVICES MARKET: BY END-USER 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast End-user
  • 6.2. Pharma & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Contract Research Organizations Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL BIOANALYTICAL SERVICES MARKET: BY REGION 2022-2034(USD MN)

  • 7.1. Regional Outlook
  • 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.2.1 By Service
    • 7.2.2 By Type
    • 7.2.3 By End-user
    • 7.2.4 United States
    • 7.2.5 Canada
    • 7.2.6 Mexico
  • 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.3.1 By Service
    • 7.3.2 By Type
    • 7.3.3 By End-user
    • 7.3.4 United Kingdom
    • 7.3.5 France
    • 7.3.6 Germany
    • 7.3.7 Italy
    • 7.3.8 Russia
    • 7.3.9 Rest Of Europe
  • 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.4.1 By Service
    • 7.4.2 By Type
    • 7.4.3 By End-user
    • 7.4.4 India
    • 7.4.5 Japan
    • 7.4.6 South Korea
    • 7.4.7 Australia
    • 7.4.8 South East Asia
    • 7.4.9 Rest Of Asia Pacific
  • 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.5.1 By Service
    • 7.5.2 By Type
    • 7.5.3 By End-user
    • 7.5.4 Brazil
    • 7.5.5 Argentina
    • 7.5.6 Peru
    • 7.5.7 Chile
    • 7.5.8 South East Asia
    • 7.5.9 Rest of Latin America
  • 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 7.6.1 By Service
    • 7.6.2 By Type
    • 7.6.3 By End-user
    • 7.6.4 Saudi Arabia
    • 7.6.5 UAE
    • 7.6.6 Israel
    • 7.6.7 South Africa
    • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

  • 8.1. Recent Developments
  • 8.2. Company Categorization
  • 8.3. Supply Chain & Channel Partners (based on availability)
  • 8.4. Market Share & Positioning Analysis (based on availability)
  • 8.5. Vendor Landscape (based on availability)
  • 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL BIOANALYTICAL SERVICES INDUSTRY

  • 9.1. Top Companies Market Share Analysis
  • 9.2. Company Profiles
    • 9.2.1 PPD Inc
    • 9.2.2 ICON Plc
    • 9.2.3 Laboratory Corporation Of America
    • 9.2.4 Charles River Laboratories International Inc
    • 9.2.5 Syneos Health
    • 9.2.6 SGS SA
    • 9.2.7 Toxikon Inc
    • 9.2.8 Intertek Group
    • 9.2.9 Pace Analytical Services
    • 9.2.10 Medpace
    • 9.2.11 PRA Health Sciences
    • 9.2.12 WuXi AppTec
    • 9.2.13 IQVIA
    • 9.2.14 Eurofins Scientific